| Views | |
|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 279 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 3 | 0 | 15 | 25 | 10 | 3 | 4 |
| Views | |
|---|---|
| journal.pone.0182852.pdf | 205 |
